Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

A step in the right direction: Encouraging diversity in clinical trial populations

On November 9, 2020, the U.S. Food and Drug Administration (FDA) released a final version of its guidance, Enhancing the Diversity of Clinical Trial Populations--Eligibility Criteria,...

Published Works

GP-led transactions are in good health Estates Gazette

In a recent article for Estates Gazette, Ed Harris, Sian Owles, Nicholas Holman, Adam Brown and Elliot Weston explore what GP-led transactions are, the common motivations for their...

Published Works

Performance in a pandemic – 10 governance and shareholder considerations for performance-based compensation C-Suite, An Equilar publication | Issue 34, Fall 2020

The uncertainty and disruption caused by the pandemic has created a challenging situation for compensation committees that need to address the impact of the pandemic on their...

Published Works

COVID-19 and fund secondaries – how should pension schemes position themselves? Investment & Pensions Europe

Partners Ed Harris, Jeremy Pickles, Faye Jarvis and Adam Brown co-wrote an Investment & Pensions Europe article which focusses on how pension funds can best position themselves to take...

News

HHS ends EUA requirement for Laboratory Developed Tests; FDA may continue to assert authority

On August 19, 2020, the U.S. Department of Health and Human Services (HHS) announced the rescission of guidances and other Food and Drug Administration (FDA) issuances concerning premarket...

News

FDA authorizes first diagnostic test for screening people without known or suspected COVID-19 infection

On July 24, 2020, the U.S. Food and Drug Administration (FDA) reissued the LabCorp COVID-19 RT-PCR Test emergency use authorization (EUA) to include two new indications for use: (1) testing ...

News

FDA proposes annual summary reporting requirements for Right to Try drug sponsors, manufacturers

On July 23, the U.S. Food and Drug Administration (FDA) announced a new proposed rule that would require sponsors and manufacturers who provide an ‘‘eligible investigational...

Media Mention

Betting on unicorns just became less hazardous for HNWIs Private Equity International

London Private Equity Partner, Ed Harris, contributed to a Private Equity International article focusing on high-net-worth-individuals (HNWIs) investing in pre-IPO businesses via the...

Hogan Lovells Publications

Strategic litigation considerations for employers in light of the Virginia Values Act

On July 1, 2020, a number of new employment laws that increase employee rights and protections took effect in Virginia. One major impact of the laws is that employers are likely to have...

Loading data